Literature DB >> 26487971

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy.

Cristina Teixidó1, Niki Karachaliou1, Maria González-Cao1, Daniela Morales-Espinosa1, Rafael Rosell1.   

Abstract

[This corrects the article on p. 87 in vol. 12, PMID: 26175924.].

Entities:  

Year:  2015        PMID： 26487971      PMCID： PMC4607823          DOI： 10.7497/j.issn.2095-3941.2015.0055

Source DB:  PubMed          Journal:  Cancer Biol Med        ISSN： 2095-3941            Impact factor:   4.248


In the published article, one error appeared on page 89. Pembrolizumab has not yet received FDA approval for NSCLC patients. In October 2014 pembrolizumab received FDA breakthrough therapy designation for lung cancer treatment supported by data from a phase Ib trial in previously treated NSCLC patients. The authors apologize for the errors and for any confusion it may have caused.
  2 in total

1.  Pembrolizumab for the treatment of non-small-cell lung cancer.

Authors:  Edward B Garon; Naiyer A Rizvi; Rina Hui; Natasha Leighl; Ani S Balmanoukian; Joseph Paul Eder; Amita Patnaik; Charu Aggarwal; Matthew Gubens; Leora Horn; Enric Carcereny; Myung-Ju Ahn; Enriqueta Felip; Jong-Seok Lee; Matthew D Hellmann; Omid Hamid; Jonathan W Goldman; Jean-Charles Soria; Marisa Dolled-Filhart; Ruth Z Rutledge; Jin Zhang; Jared K Lunceford; Reshma Rangwala; Gregory M Lubiniecki; Charlotte Roach; Kenneth Emancipator; Leena Gandhi
Journal:  N Engl J Med       Date:  2015-04-19       Impact factor: 91.245

Review 2.  Assays for predicting and monitoring responses to lung cancer immunotherapy.

Authors:  Cristina Teixidó; Niki Karachaliou; Maria González-Cao; Daniela Morales-Espinosa; Rafael Rosell
Journal:  Cancer Biol Med       Date:  2015-06       Impact factor: 4.248
  2 in total
  2 in total

Review 1.  The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1.

Authors:  Zhaohui Jin; Harry H Yoon
Journal:  J Gastrointest Oncol       Date:  2016-10

Review 2.  Positive and negative functions of B lymphocytes in tumors.

Authors:  Meng Shen; Qian Sun; Jian Wang; Wei Pan; Xiubao Ren
Journal:  Oncotarget       Date:  2016-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.